SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Shafi S, Diaz-Arrastia R, Madden C, Gentilello L. J. Trauma 2008; 64(2): 335-340.

Affiliation

Division of Burns, Department of Surgery, Trauma Critical Care, University of Texas Southwestern Medical School, Dallas, Texas, USA. shahid.shafi@utsouthwestern.edu

Comment In:

J Trauma 2008;65(2):500-1.

Copyright

(Copyright © 2008, Lippincott Williams and Wilkins)

DOI

10.1097/TA.0b013e31815dd017

PMID

18301195

Abstract

BACKGROUND: The Brain Trauma Foundation (BTF) recommends intracranial pressure (ICP) monitoring in traumatic brain injury (TBI) patients with Glasgow Coma Scale (GCS) of 8 or less, and an abnormal brain computed tomography. However, benefits of ICP monitoring have not been documented. We hypothesized that BTF criteria for ICP monitoring in blunt TBI do not identify patients who are likely to benefit from it.

METHODS: The National Trauma Data Bank (1994-2001) was analyzed. Inclusion criteria were blunt TBI, head-abbreviated injury score (AIS) 3 to 6, age 20 to 50 years, GCS 24 hours after injury) were excluded. Patients who underwent ICP monitoring (n = 708) were compared with those did not (n = 938). Multivariate logistic regression was used to determine the relationship between ICP monitoring and survival, while controlling for overall injury severity, TBI severity, craniotomy, associated injuries, comorbidities, and complications.

RESULTS: ICP monitoring was performed in only 43% of patients who met BTF criteria. There were no group differences in age, gender, or GCS. After adjusting for multiple potential confounding factors including, admission GCS, age, blood pressure, head AIS, and injury severity score (ISS), ICP monitoring was associated with a 45% reduction in survival (OR = 0.55; 95% CI, 0.39-0.76; p < 0.001).

CONCLUSIONS: ICP monitoring in accordance with current BTF criteria is associated with worsening of survival in TBI patients. A prospective randomized controlled trial of ICP-guided therapy is needed. Until then, the use of ICP monitoring should not be used as a quality benchmark.


Language: en

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print